Labcyte Inc.

Labcyte Echo Acoustic Liquid Handler an Essential Component of Pharmaceutical High-Throughput Screening

(04 Aug 2009)

For Immediate Release 

Contact: 

Joe Olechno, Ph.D.  

Labcyte Inc. 

1190 Borregas Avenue 

Sunnyvale, CA 94089 

Toll free: 877 742 6548 

Tel: 408 747 2000 x161 

Fax: 408 747 2010 

Email: Joe.Olechno@Labcyte.com  

www.labcyte.com 

 

Labcyte Echo Acoustic Liquid Handler an Essential Component 

of Pharmaceutical High-Throughput Screening  

Recent Issue of JBS Emphasizes the Importance of Acoustic Liquid Handling in 

Drug Discovery 

 

Sunnyvale, CAAugust 4, 2009 — The most recent edition of the Journal of Biomolecular 

Screening, the world’s leading peer-reviewed publication on drug discovery sciences, focused on 

the significant advances made recently in the field of compound management. In this special 

edition over half of the sixteen articles specifically mention the Labcyte Echo® liquid handlers. 

Of particular interest is the article by Grant et al., AstraZeneca, which states, “In summary, the 

introduction of the Echo acoustic reformatter has represented a major milestone in 

pharmaceutical screening applications. It has revolutionized the compound management process 

to support HTS.” (http://jbx.sagepub.com/cgi/reprint/14/5/452)  

 

In the paper by Zaragoza-Sundqvist et al., Astra Zeneca,the authors said, “Four years ago, the 

first acoustic droplet ejectors (ADEs) were launched on the market, providing a new generation of 

high throughput noncontact liquid handlers that outclassed traditional contact instruments in 

almost every respect...Higher quality is achieved through greater accuracy and precision, 

whereas lower sample volumes can be used, and 1536 plate formats have become a reliable 

reality.” (http://jbx.sagepub.com/cgi/reprint/14/5/509) 

 

Articles by Matson et al., Bristol-Myers Squibb, (http://jbx.sagepub.com/cgi/reprint/14/5/476), 

Pfeifer and Scheel, Novartis, (http://jbx.sagepub.com/cgi/reprint/14/5/492) and Blaxill et al., 

GlaxoSmithKline, (http://jbx.sagepub.com/cgi/reprint/14/5/547) use the acoustic auditing 

capabilities of the Labcyte Echo technology to determine the volume of wells and the level of 

DMSO hydration.  

Labcyte Echo liquid handlers use sound to move a wide range of liquids. Eliminating physical 

contact with the sample makes the transfer contamination-free as well as extremely precise and 

accurate for a wide range of life science applications. The system has a working range from 2.5 

nL to many microliters. Echo liquid handlers automatically measure the depth of fluid in each 

source well, informing the user of the quantity and quality of samples. This technology is 

especially well suited to biological applications in which precision measurements are critical and 

cross-contamination of samples can interfere with accurate interpretation of the results. Software 

especially designed for cherry-picking, dose-response set-up and plate reformatting, optimize the 

system ease-of-use. 

About Labcyte 

Labcyte Inc. uses sound to move liquids. This green technology provides significantly better 

analytical results while saving money. The ‘touchless’ technology provides dramatically better 

answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving 

hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first 

drop through last for a wide variety of fluids, including many considered intractable by other 

techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader 

in liquid handling. Together with the Deerac systems, the award-winning Echo® liquid handlers 

are used in all of the top 10 pharmaceutical companies, as well as in leading academic and 

research institutions worldwide. Labcyte technologies have broad applications including the fields 

of compound management, genomics, proteomics, particle manufacturing, encapsulation, 

imaging mass spectrometry, and live-cell transfer. Labcyte is headquartered in Sunnyvale, 

California with offices in Dublin, Ireland and has 39 U.S., 7 European and two Japanese patents 

and additional U.S. and international filings.  For more information, visit www.labcyte.com. 


 
© 2012 Labcyte Inc.